Jason Willis - Concepedia

Author

Jason Willis

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

J Willis, J. Willis, J.A. Willis, Jason A Willis, Jason A. Willis, Jason Willis, Jason willis, Willis, Jason

171

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Guardant (United States)University of Pennsylvania Memorial Sloan Kettering Cancer Center University of North Carolina at Chapel Hill

About

Jason Willis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	941
2	Immunology	3	3	104
3	Health Sciences	1	1	31
4	Public Health	1	1	20
5	Molecular Genetics	1	1	20

Jason Willis

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Mammalian Mirtron Genes Eugène Berezikov, Wei-Jen Chung, Jason Willis, Molecular Cell MedicineGeneticsSmall RnaGene ExpressionMammalian Mirtron Genes	2007	786
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel Jason Willis, Martina I. Lefterova, Alexander Artyomenko, Clinical Cancer Research	2019	230
Survival improvement for patients with metastatic colorectal cancer over twenty years Fadl A. Zeineddine, Mohammad A. Zeineddine, Abdelrahman Yousef, npj Precision Oncology	2023	156
Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancer. Van K. Morris, Christine M. Parseghian, Michelle Escano, Journal of Clinical Oncology Braf V600e CrcImmunologyPathologyImmunotherapeuticsImmunotherapy	2022	76
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, npj Precision Oncology	2024	75
Resistance Mechanisms to Anti–Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy Christine M. Parseghian, Ryan Sun, Melanie Woods, Journal of Clinical Oncology	2022	63
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2 Kyle Chang, Jason Willis, Joke Reumers, Annals of Oncology	2018	49
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Clinical Cancer Research	2021	49
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial Ethan B. Ludmir, Alexander D. Sherry, Bryan Fellman, Journal of Clinical Oncology	2024	46
Estrogen and progesterone receptor detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: a comparison of immunohistochemistry with the dextran-coated charcoal assay. D C Wilbur, Jason Willis, Robert A. Mooney, PubMed	1992	45

Page 1